Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...

Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

A new nasal drug has been approved to treat depression. The drug Spravato  is a nasal spray made by Johnson and Johnson.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...

Follow Boston.com on Instagram (Opens in a New Tab) Follow Boston.com on Twitter (Opens in a New Tab) Like Boston.com on Facebook (Opens in a New Tab) ...

Eylea (aflibercept) is a prescription drug that treats certain eye conditions. Eylea can cause side effects that range from mild to serious. An example includes cataracts, which may become a long ...

It is certainly possible that a person finds that one of these nasal steroids works better or causes fewer side effects than another. There may be some advantages and disadvantages of using Flonase or ...

“Additionally, several patients are worried about rapid hair loss side-effects and are requesting non-surgical treatments to improve hairlines. They are desperate to get their hands on these drugs, ...

The Hansjörg Wyss Department of Plastic Surgery offers medical students at NYU Grossman School of Medicine and outside medical schools a summer research program in which they gain valuable exposure to ...